Skip to main content

Industrial Apparatuses in Confrontation

From the series The struggle against coronavirus

According to the British analyst firm Airfinity, some 9.5 billion doses of Covid-19 vaccines will be produced worldwide in 2021. This number is double the annual production of all types of vaccines in the pre-pandemic era (5 billion, excluding oral polio, travellers’ and military vaccines), and can be compared with the requirement of 11.5 billion to immunise two-thirds of the world’s population [Airfinity, March 8th]. The development of vaccines has been exceptionally rapid, but manufacturing them on a large scale has encountered difficulties and delays. In 2020, only 4% of the expected doses were in fact produced [ibidem].

Production is concentrated in a limited number of countries, largely interdependent due to supply chains that cross state borders and continents. The World Bank identifies, among the producing countries, a Covid-19 vaccine producers club of 13 countries that manufacture both the active ingredient and its components. This exclusive Vaccine Club is also awarded 60% of the total Advance Purchase Agreements (APAs) — the advance purchase of vaccines — with pharmaceutical companies [World Bank, The Covid-19 vaccine production club, March 2021].

The World Bank’s concern is that aggressive forms of vaccine nationalism , by limiting exports, are disrupting global supply chains. For its part, the World Health Organization (WHO) fears that in much of the world, such as in Africa, vaccines will not arrive until 2023 or 2024.

Crippled internationalism

In June last year, the Global Vaccine Alliance (GAVI), together with the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO, launched the COVAX programme. It covers 192 countries, with the aim of ensuring equitable global distribution of vaccines, initially providing two billion doses, two-thirds free of charge, to 92 lower-income countries. Donations were in short supply and, two months into the vaccination campaign, COVAX had still not been able to deliver a single dose to the poorest countries [Financial Times, February 13th]. Initially conceived as a single clearing house for vaccine orders around the world, from which all countries, rich and poor, would procure their doses, notes the City newspaper, the program almost immediately foundered in the race for bilateral deals between the richest nations and the vaccine companies, and the priority allocation to domestic needs practised by countries like the United States, the UK and, more recently, even India.

Limited production, coupled with the supply dispute that has arisen between the European Commission and pharmaceutical companies — in particular with the Anglo-Swedish company AstraZeneca — has prompted several European leaders (and various scientific and political figures) to raise the issue of patents. The President of the European Council Charles Michel at the beginning of the year raised the possibility of the EU adopting ‘urgent measures’ — provided for in Article 122 of the Treaty — to impose ‘compulsory licensing’ on companies [Politico, February 3rd]. In fact, last December, the request made by some countries, including India and South Africa, for companies to waive patent exclusivity was rejected by the United States, the UK and the EU [The New York Times, December 25th].

The protection of intellectual property is regulated by the TRIPS (Trade Related Aspects of Intellectual Property Rights) agreement of the World Trade Organization (WTO). The amendment, adopted at the Doha Conference in 2001 and subsequently clarified, provides for the right of a state, in the event of a national health emergency, to produce (or have a third-party produce) a drug without the permission of the company holding the patent on the product or its manufacturing process. In 2017, two-thirds of the WTO membership had ratified the amendment, making it operational.

The compulsory licence could facilitate the entry of new companies into the market, but it still leaves the problem of production capacity for high-technology medicines (such as new vaccines) unsolved.

A kind of ‘vaccine internationalism’ is called for by many. Its realization presupposes, however, the overcoming of barriers and conflicts, commercial and otherwise, between states, and of competition between economic groups; it involves the pooling of resources and productive capacity, the coordination and direction of the global production of vaccines and their distribution according to public needs worldwide. At the very least, it means stripping vaccines of their characteristics of a commodity, which is the form in which the products of human labour are presented in the capitalist social system.

The critics of neoliberalism and globalization stop at the threshold of criticizing the very foundations of the capitalist socio-economic formation. They instead lash out at the excessive power of the banks or the greed of the multinationals, etc., and cultivate the illusion that it is possible to eliminate some of these most odious, but inevitable, forms of capitalism in its imperialistic maturity. Lenin called this wishful thinking.

Production sites for Covid-19 vaccines in the EU and the UK.

Production sites for Covid-19 vaccines in the EU and the UK. In some plants (highlighted in red) the biological active substance is produced, in others the final stages of production, such as bottling and packaging, are carried out. Some of the facilities belong to the company that owns the vaccine, while more than half belong to companies that work on behalf of third parties (CDMO, Contract Development and Manufacturing Organization). Four vaccines are licensed in the EU (BioNTech/Pfizer, Oxford/AstraZeneca, Moderna and J&J); the others are under review by regulatory bodies (CureVac and Novavax) or are still undergoing clinical trials.

Sources: EDJNet — European Data Journalism Network, March 5th, European Commission; corporate communications.

Industrial powers in confrontation

Airfinity calculates that at the end of March the production of Covid-19 vaccines stood at 229 million doses in China, 164 in the US, 125 in India, 110 in the EU (three quarters of which are in Germany, Belgium and the Netherlands), and 16 in the UK. China exported 48%, India 44% and the EU 42%. The USA and the UK have kept all of their doses for their domestic markets [Airfinity, March 24th].

Internal Market Commissioner Thierry Breton believes the EU is winning the industrial battle: producing — he writes — over 200 million doses of vaccines, reaching current levels of production in the US, and the Union’s annual production capacity is expected to reach 3 billion doses by the end of the year. Breton also lays claim to the Union’s role as a top exporter worldwide. At least two-thirds of the 30 million doses administered in Britain were produced in Europe, and the UK depends on the EU for the second dose [European Commission, Beating COVID-19: Scale-up of vaccine production in Europe, April 8th].

Breton refers to 53 production sites for Covid-19 vaccines in Europe. 26% of the facilities are located in Germany. Together with the Netherlands and Belgium, the three countries host 40% of the sites, which in some cases produce more than one type of vaccine. In fact, at least thirty or so plants are owned by companies working on behalf of third parties (CDMO, Contract Development and Manufacturing Organization), of around ten nationalities, mostly German, Spanish and American.

The EU, writes Breton, is an industrial power that is and intends to remain a global player, rejecting vaccine nationalism. The European Commission has, however, since last January, made exports of vaccines subject to authorization. The EU, comments The Economist, is torn between its reputation as champion of open markets and the needs of internal supply [March 27th].

There is an ongoing struggle between the metropolises over health. The production capacity of vaccines, as well as the organisational efficiency in carrying out vaccination strategies — a precondition for a less or more rapid economic recovery — is a measure of the overall strength of states in the global competition.

Lotta Comunista, April 2021

Labels:

Popular posts from this blog

The British Link in the Imperialist Chain

Internationalism No. 33, November 2021 Page 8 Lenin often used the metaphor of a chain that binds the world to describe imperialism. The October Revolution of 1917 broke a first link in that chain and hoped to pull the whole thing loose. The metaphor was adopted in those years by all the Bolshevik leaders and the leaders of the newly formed Third International. Within a decade, Stalin's well-known formula of socialism in one country signified the overturning of that strategic cornerstone and the defeat of the revolution in Russia, in Europe, and in the world. Dates that have come to symbolise historical change act as the synthesis of previously accumulated contradictions, and, while such a sudden change does not exhaust the possibility of future contradictions, the concentration of events in 1926 nonetheless marked a watershed that revealed the true extent that the counter-revolution had reached. The great general strike in the United Kingdom that year, wh...
Read more

Socialism and Nationalism in the History of France

The collapse of French socialism at the outbreak of the First World War is considered by many historians to be the most significant case of its kind. We must go back in time to find its origins. The dramatic repression of the Paris Commune in 1871 was followed by a decade of shootings and the deportation of tens of thousands of revolutionary militants. Reactionary monarchical legitimism attributed the decline of France to the Revolution of 1789, but by then the nouvelles couches sociales , the new classes produced by capitalism, as Leon Gambetta defined them, demanded a politics free from economic, social and clerical ties. The Radical Party, a turning point of French politics, was its expression. The same taditional Catholic Judeophobia dating back to the Middle Ages — according to Michel Dreyfus’, research director at the CNRS in Paris, Anti-Semitism on the Left in France [Paris, 2009] — gradually transformed into the image of the Jews associated with money and modernity who des...
Read more

The Chinese Dragon Does Not Wait for American Rearmament

From the series News from the Silk Road According to The Washington Post , through the federal budget the White House has opened negotiations with the Senate that include long-term competition with China. The figures — $6 trillion, including infrastructure and family welfare plans — will vary in the negotiations, and will be centred on three directives. One demand is common to various proposals of expenditure: they must have a positive impact on the American productivity vis-à-vis China on the open fronts of industrial, energy and technological restructuring, or on the efficiency of welfare systems. In the case of welfare, the competition is also vis-à-vis Europe. Another calculation, attributed to Biden’s administration and the Democrats, is the enlargement of the electoral coalition in view of the next mid-term elections. Finally, there is a need to direct military expenditure, within the framework of a greater increase in the other items of discretionary expenditure, not absorb...
Read more

Science Against Time

Internationalism No. 73, March 2025 Page 14 From the series Industry and pharmaceuticals The surge in China’s biopharmaceutical industry over the last decade is part of its broader scientific and technological ascent and therefore deserves our attention. Such growth presents a challenge to other imperialist powers. The Biosecure Act’s intention, to reduce the ties between American and Chinese biotech firms, has been branded by The Economist as “old-fashioned protectionism”. The British weekly recognises, however, that the clash goes well beyond a trade war. The stakes are higher. In a lengthy cover story [“The rise of Chinese science”], it writes that “China is now a leading scientific power”. Just five years ago, this was still considered only a possibility. The current question is whether this is “welcome or worrying” [June 15th, 2024]. Unity and scission The viewpoint of that publication, an authoritative voice of one of the power-houses of imperia...
Read more

Another Kind of Politics

Donald Trump has said goodbye as befits his fame, with a tragic riotous revelry. A crowd with improbable disguises took its cue from the fake news on the Internet fomented by the presidency, assaulted the Capitol and wandered around its rooms and corridors with the aim of intimidating representatives and senators. All of this, however, taking selfies: a moment of fame on Facebook or YouTube and a trophy to show off back home in deepest America, while carousing in the local pub. His successor Joe Biden will seek a rebalance in a bipartisan collaboration, but he cannot escape from the dominant trait now characterising the political show . The swearing-in ceremony was the enthronement of a republican king, according to the rites of Hollywoodian show business: pop singers, actors, directors, and rock stars, and the new reigning couple hand in hand as they admired the fireworks in the night. Meanwhile, on the other shore of the Atlantic, a similar depressing show is going on the air with ...
Read more

The future of work in Europe

Every moment of transition presents its own complexities: for our class this means that further divisions are sown within it. Such is the present moment — one when different dynamics stack up and intertwine. Past, present and future On the one hand, there is the troubled exit from the pandemic crisis, still under the threat posed by the emergence of new Covid-19 variants. The pause on redundancies has come to an end in Italy. This, albeit partially, would have spared about 520,000 jobs in Italy up until now, according to Centro Einaudi’s estimates [ 25 th Annual Report on Global Economy and Italy , June 2021]. Company closures and staff reductions (in a mixture of arrogance and callousness) have marked the summer months, only to announce a difficult autumn, when the redundancy ban will be lifted also for small businesses and services. However, it is clear how uncertain the workers’ condition remains, regardless of any collective agreement signed, and how necessary it is always to ...
Read more

German Socialism in 1917

Internationalism No. 78-79, August-September 2025 Page 6 From the series Pages from the history of the worker’s movement  According to Arrigo Cervetto [ Opere , Vol. 7], “paracentrism” is “the biggest obstacle to the formation of the worldwide Bolshevik party”. The Spartacists at Zimmerwald and Kiental Cervetto was analysing Lenin’s battle against centrism for the creation of the Third International, a battle which saw him isolated at Zimmerwald. He wrote down one of Zinoviev’s quotations from Histoire du parti communiste russe . “We were in the minority at Zimmerwald [1915]. […] In the years 1915 and 1916, we were nothing but an insignificant minority”. “But what is more serious?” – observed Cervetto – “is that the Zimmerwald Spartacists also said they were opposed to us”. In the strategic perspective of the “two separate halves” of socialism – the political conditions in Russia and the economic, productive, and social conditions in Germany – “for ...
Read more

Militarised Scientists

Internationalism No. 71, January 2025 Page 13 From the series Atom and industrialisation of science “ The bourgeoisie has stripped of its halo every occupation hitherto honoured and looked up to with reverent awe. It has converted the physician, the lawyer, the priest, the poet, the man of science, into its paid wage labourers ” [Marx and Engels, The Communist Manifesto ). The Manhattan Project scientists In Brighter Than a Thousand Suns: A Personal History of the Atomic Scientists , Robert Jungk [1913-1994] writes that the Manhattan Project was a labyrinth of winding paths and dead ends. Commenting on Jungk’s romanticised account of the first phase of the history of the atomic bomb, Edward Teller [1908-2003], often called the “father” of the H-bomb, wrote: “There is no mention of the futile efforts of the scientists in 1939 to awaken the interest of the military authorities in the atomic bomb. The reader does not learn about the dismay of scientists f...
Read more

The Theoretical and Political Battles of Arrigo Cervetto I

From the introduction to Arrigo Cervetto’s Opere Scelte (“Selected Works”), soon to be published in Italy by Edizioni Lotta Comunista. I Arrigo Cervetto was the founder, theorist, and leader of Lotta Comunista. From his first involvement in the partisan war in 1943-44 until his death in February 1995, his more than 50 years of political activity can be summarised in around twenty key battles. It goes without saying that those struggles - aimed at the restoration and develop ment of Marxist theory on economics, politics, social change, and international relations - are the common thread running through this selection of his writings. His memoirs, Quaderni 198I82 (“Notebooks 1981-82”), provide an account of those battles up to 1980. First battle: the factory and the partisan war The son of emigrants to Argentina from Savona in Italy, Cervetto was born in Buenos Aires in April 1927, a circumstance that would later influence his thinking about international politics. His early for...
Read more

Trump Relaunches the Tariff War

Internationalism No. 73, March 2025 Page 9 In January 2017, as soon as he took office in the White House, Donald Trump signalled the new trade policy of the United States with two immediate moves: the exit from the TransPacific Partnership (TPP) and the project for a wall on the border with Mexico. These were accompanied by the threat to abandon the North American Free Trade Agreement (NAFTA). That thunderous debut now seems almost moderate, compared to the flurry of arrogant announcements and orders with which his second presidency has begun. Multiple fronts In just a few weeks, Trump has deployed an impressive and omni-directional arsenal of tariffs, making no distinction between allies and adversaries. The first targets were imports from Canada and Mexico, the US’s biggest trading partners. These 25% tariffs were immediately put on hold for a month, in exchange for symbolic concessions from the two neighbouring governments, aimed at countering the suppos...
Read more